Cardiology & Emergency Medicine – 2026 Package
This comprehensive overview of cardiology examines Cardio-athletics, heart failure, cardiac pharmacology and STEM equivalents. Includes case studies and real-life examples that will refresh your skills and improve your patient outcomes.
CME On-Demand Courses Include

Walks Like a Duck, Talks Like a Duck… But It’s a Zebra: Evaluation of Cardiac and Non-Cardiac Chest Pain
Chest pain can be very confusing due to the inconsistent presentation of symptoms. This session will discuss the complex evaluation of cardiac and non-cardiac chest pain using case studies and covering topics such as acute coronary syndrome, pulmonary emboli, gastroesophageal reflux disease and acute dissections.
Getting to the Heart of Cardio-Athletics and Athletic Cardiomyopathy
Cardio-Athletics is an emerging topic in primary care, yet Athletic Cardiomyopathy is still poorly understood. This session will discuss the basics of cardio-athletics and define the differences between an “Athlete’s Heart” and true Athletic Cardiomyopathy responsible for sudden cardiac death.
Imaging is Not for the Faint Hearted: Use of EKGs and Echocardiography in the Management of Cardiac Disease
EKGs and echocardiography may be the two most used imaging studies in cardiac medicine. This session will discuss the fundamental yet systematic interpretation of EKGs, the advanced understanding of EKG interpretation, and the naked bird’s eye view of echocardiography imaging when treating cardiac disease.
I’m Going to Pump – You Up: The A to Z Continuum of Heart Failure (Rx=0.25)
The continuum of heart failure is an ongoing plague to society. This session will explore the heart failure continuum, including symptomatology and diagnosis, initiation of guideline-driven medical therapy for heart failure, the importance of the “90-day” echocardiogram, subsequent ICD therapy and what to do when nothing else is working.
Living in a State of Shock: Everything You Wanted to Know and More About Cardiogenic Shock
There is a steady trend of prevalence of cardiogenic shock globally, becoming a strain on the health care system. This session will discuss symptomatology, the risk of delayed shock diagnosis, management and treatment of cardiogenic, and urgency in shock reversal.

Cardiac Pharmacology Review: What’s New in the Medicine Cabinet (Rx=0.75)
This session will provide a pharmacologic review of hypertension, the newer agents in the lipid and heart failure space, POTS and Migraines and when to reach for them.
Heart Failure Guidelines and Cases (Rx=0.25)
This session will discuss the new heart failure drugs and when to reach for them. We will also cover the latest heart failure criteria and classifications/stages.
Basic 12 Leads Demystified
This lecture systematically reviews how to approach a 12 lead EKG and find contiguous leads, reciprocal changes, and bundle branch blocks.
Critical Cardiology Cases
This lecture covers cardiology complaints like PE and how to spot one on the EKG. We will also review a case scenario where a 39-year-old female had a sudden coronary artery dissection, the clues that solved the case, and how to tell the difference between ischemia and lvh on the EKG.
Sneaky Cases of ACS: New STEMI Equivalents You Must Know to Stay Safe
We will explore the new stemi equivalents that will be read as non-specific st segment changes but need to go to the cath lab. We will identify subtle ischemia that does not meet stemi criteria but does need urgent angiography. Actual EKGs will be reviewed.
Cardiology / Obesity – 2025 Package
Top-rated speakers Viet Le, DMSc, PA-C, FACC, FAHA, HF-Cert, and Angela Golden, DNP, FNP-C, FAANP, FOMA, deliver a comprehensive overview of cardiology CME topics, from managing obesity to preventing peripheral artery disease.
CME On-Demand Courses Include

“Arrhythmia’s Gonna Get You” – Atrial Fibrillation (Rx=0.25)
This course reviews the most common arrhythmia, Atrial Fibrillation and discusses diagnosis and the acute/chronic management through lifestyle and implications of pharmacologic treatment.
“Under Pressure” – Hypertension (Rx=0.25)
This course reviews updated guidelines and the importance of early diagnosis and intensive treatment of Hypertension as well as diagnosis and chronic management through lifestyle and pharmacologic treatment.
“Head Above Water” – Heart Failure (Rx=0.25)
This course reviews updated Heart Failure guidelines by discussing chronic management through lifestyle and the importance of pharmacologic treatment.
“Heart Attack” – Coronary Artery Disease (Rx=0.50)
This course reviews the continuum of coronary artery disease from acute coronary syndrome to chronic management. Chronic management through lifestyle and the importance of pharmacologic treatment will also be discussed.
“I Can’t Walk 500 Miles” – Peripheral Artery Disease
Our speaker discusses peripheral arterial disease and the importance of screening and early intensive management to reduce the risk of amputations and other cardiovascular disease events through lifestyle and pharmacologic treatment.

Treating Obesity Can Treat the Heart and Much More: 200+ Obesity Complications
In this course, the speaker utilizes case studies and reviews the explanation of how obesity is at the root of 236 obesity-associated disorders. Pathophysiology of the disease of obesity and its consequences, with an explanation of treatment that targets obesity and the complications, is also to be discussed.
Cardiometabolic Treatment for Obesity (Rx=0.25)
This course delivers on overview of the intersection of obesity, T2DM, and hypertension pathophysiology and sets the stage for understanding how traditional and novel anti-obesity therapies impact these diseases and the cardiac implications.
Managing Obesity in Primary Care: Yes, It Can Be Done (Rx=0.25)
Most primary care providers ask, “How can I add another disease to be treated to my already very busy schedule, especially one that is impacting so many of my patients?” This course includes a case study to demonstrate how to integrate the treatment of obesity into primary care using evidence-based guideline treatment.
Treating Obesity Inside and Outside the Labels (Rx=0.50)
Today’s reality for pharmacology treatment of obesity on-label provides limited choices, including those limited by cost. Experienced clinicians treating obesity recognize the value of on-label prescribing but also look to off-label use of medications for obesity treatment. This course briefly reviews current FDA-approved medicines for the long-term treatment of obesity. The course then focuses on long-term use of FDA-approved short-term medications and medications known to support weight loss but that do not have FDA approval for that purpose. Case studies will be utilized to demonstrate these situations.
Treatment of Complicated Patients with Obesity (Rx=0.50)
Obesity is the most common chronic disease in the United States and is at the root of over 236 complications, including 14 obesity-related cancers. This course presents case studies and a review of treatment plans for patients with multiple chronic diseases.